Evidence map›Paper›PMID 20156738›Full record

ArticleEuropean journal of medical research2009

Increased FKBP51 in induced sputum cells of chronic obstructive pulmonary disease patients after therapy.

A Holownia, R M Mroz, A Kolodziejczyk, E Chyczewska, J J Braszko

Open access · bronzeAbstract read
In one paragraph

Article in European journal of medical research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Frontiers in immunology · 2017
    Article
  7. Glucocorticoid therapy and ocular hypertension.European journal of pharmacology · 2016
    Review
  8. Review
  9. Article
  10. Article
  11. FKBP51 and FKBP52 in signaling and disease.Trends in endocrinology and metabolism: TEM · 2011
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

A HolowniaDepartment of Clinical Pharmacology, Medical University of Bialystok, Poland. Holow_sinai@hotmail.com
R M Mroz
A Kolodziejczyk
E Chyczewska
J J Braszko
Medical University of Białystok · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveImmunophilin FKBP51 assists polypeptide folding, participates in glucocorticoid actions and may play a role in glucocorticoid resistance. FKBP51 is altered in patients with asthma, but its role in chronic obstructive pulmonary disease (COPD) characterized by dysregulation of several pro/antiinflammatory genes is less clear.

methodsWe assessed changes in nuclear/cytosolic FKBP51 protein using SDS-PAGE/WB and FKBP51 mRNA by qRT-PCR in cells isolated from induced sputum of stable COPD patients treated with formoterol/budesonide or formoterol/budesonide/theo?phylline for 4 wk.

resultsExpression of FKBP51 was higher in formoterol/ budesonide/theophylline-treated patients, compared with formoterol/budesonide group in both cytosolic and nuclear fractions by about 57% and 31%, respectively (P<0.001, P<0.01). FKBP51 mRNA was only slightly, but not significantly, higher in patients on formoterol/ budesonide/theophylline.

conclusionsIncreased FKBP51 in COPD patients treated with formoterol/ budesonide/theophylline may be important in altering signaling from corticosteroid receptors.

Indexed as

BudesonideDrug Therapy, CombinationEthanolaminesFormoterol FumarateHumansPulmonary Disease, Chronic ObstructiveRNA, MessengerSputumTacrolimus Binding Protein 5Tacrolimus Binding ProteinsTheophyllineBudesonideEthanolaminesFormoterol FumarateRNA, MessengerTacrolimus Binding Protein 5Tacrolimus Binding ProteinsTheophylline

Identifiers

PMID20156738
PMCPMC3521382
OpenAlexW2036918981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.